Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 50

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes

Mastrofrancesco, A., Ottaviani, M., Cardinali, G., Flori, E., Briganti, S., Ludovici, M., Zouboulis, C.C., Lora, V., Camera, E., Picardo, M. · 2017 · Biochemical Pharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bcp.2017.04.030

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 43

  1. Moradi Tuchayi, 2015, Acne vulgaris, Nat. Rev. Dis. Primers, 1, 15029, 10.1038/nrdp.2015.29 · DOI · Paper page
  2. Ghodsi, 2009, Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study, J. Invest. Dermatol., 129, 2136, 10.1038/jid.2009.47 · DOI · Paper page
  3. Makrantonaki, 2011, An update on the role of the sebaceous gland in the pathogenesis of acne, Dermatoendocrinology, 3, 41, 10.4161/derm.3.1.13900 · DOI · Paper page
  4. Zouboulis, 2014, Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions, J. Eur. Acad. Dermatol. Venereol., 28, 527, 10.1111/jdv.12298 · DOI · Paper page
  5. Tan, 2015, A global perspective on the epidemiology of acne, Br. J. Dermatol., 172, 3, 10.1111/bjd.13462 · DOI · Paper page
  6. Bhate, 2013, Epidemiology of acne vulgaris, Br. J. Dermatol., 168, 474, 10.1111/bjd.12149 · DOI · Paper page
  7. Paraskevaidis, 1998, Polymorphisms in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne, Dermatology, 196, 171, 10.1159/000017855 · DOI
  8. Yang, 2013, Association of HSD17B3 and HSD3B1 polymorphisms with acne vulgaris in Southwestern Han Chinese, Dermatology, 227, 202, 10.1159/000353581 · DOI
  9. Navarini, 2014, Genome-wide association study identifies three novel susceptibility loci for severe Acne vulgaris, Nat. Commun., 5, 4020, 10.1038/ncomms5020 · DOI
  10. Agamia, 2016, Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet, Br. J. Dermatol., 174, 1299, 10.1111/bjd.14409 · DOI
  11. Monfrecola, 2016, Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin, Exp. Dermatol., 25, 153, 10.1111/exd.12885 · DOI
  12. Huang, 2014, Growing knowledge of the mTOR signaling network, Semin. Cell Dev. Biol., 36, 79, 10.1016/j.semcdb.2014.09.011 · DOI · Paper page
  13. Melnik, 2013, Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne, Exp. Dermatol., 22, 311, 10.1111/exd.12142 · DOI · Paper page
  14. Sertznig, 2008, Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases, Am. J. Clin. Dermatol., 9, 15, 10.2165/00128071-200809010-00002 · DOI
  15. Sertznig, 2011, Peroxisome proliferator-activated receptors (PPARs) in dermatology: challenge and promise, Dermatoendocrinology, 3, 130, 10.4161/derm.15025 · DOI
  16. Mastrofrancesco, 2014, Preclinical studies of a specific PPARgamma modulator in the control of skin inflammation, J. Invest. Dermatol., 134, 1001, 10.1038/jid.2013.448 · DOI
  17. Icre, 2006, Functions of the peroxisome proliferator-activated receptor (PPAR) alpha and beta in skin homeostasis, epithelial repair, and morphogenesis, J. Investig. Dermatol. Symp. Proc., 11, 30, 10.1038/sj.jidsymp.5650007 · DOI
  18. Yessoufou, 2010, Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels, Swiss Med. Wkly., 140, w13071
  19. Klein, 2007, What are subcutaneous adipocytes really good for?, Exp. Dermatol., 16, 45, 10.1111/j.1600-0625.2006.00519_1.x · DOI
  20. Nehrenheim, 2013, Dihydrodehydrodiisoeugenol enhances adipocyte differentiation and decreases lipolysis in murine and human cells, Exp. Dermatol., 22, 638, 10.1111/exd.12218 · DOI
  21. Rosenfield, 1999, Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors, J. Invest. Dermatol., 112, 226, 10.1046/j.1523-1747.1999.00487.x · DOI
  22. Downie, 2004, Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro, Br. J. Dermatol., 151, 766, 10.1111/j.1365-2133.2004.06171.x · DOI
  23. Higgins, 2010, Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation, Am. J. Clin. Nutr., 91, 267S, 10.3945/ajcn.2009.28449E · DOI · Paper page
  24. Ramot, 2014, Advanced inhibition of undesired human hair growth by PPARgamma modulation?, J. Invest. Dermatol., 134, 1128, 10.1038/jid.2013.473 · DOI
  25. Zouboulis, 1999, Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95), J. Invest. Dermatol., 113, 1011, 10.1046/j.1523-1747.1999.00771.x · DOI · Paper page
  26. Flori, 2011, 2,4,6-Octatrienoic acid is a novel promoter of melanogenesis and antioxidant defence in normal human melanocytes via PPAR-gamma activation, Pigment Cell. Melanoma Res., 24, 618, 10.1111/j.1755-148X.2011.00887.x · DOI
  27. Smith, 2008, IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway, J. Invest. Dermatol., 128, 1286, 10.1038/sj.jid.5701155 · DOI · Paper page
  28. Smith, 2008, The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides, J. Dermatol. Sci., 50, 41, 10.1016/j.jdermsci.2007.11.005 · DOI · Paper page
  29. Renier, 1996, Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production, Endocrinology, 137, 4611, 10.1210/endo.137.11.8895324 · DOI
  30. Kooijman, 2003, IGF-I stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase, Cell. Signal., 15, 1091, 10.1016/S0898-6568(03)00069-X · DOI
  31. Rudman, 1997, The role of IGF-I in human skin and its appendages: morphogen as well as mitogen?, J. Invest. Dermatol., 109, 770, 10.1111/1523-1747.ep12340934 · DOI · Paper page
  32. Makrantonaki, 2008, Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro, Exp. Gerontol., 43, 939, 10.1016/j.exger.2008.07.005 · DOI
  33. Graham, 2004, Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL, Br. J. Dermatol., 150, 421, 10.1046/j.1365-2133.2004.05762.x · DOI · Paper page
  34. Kang, 2005, Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo, Am. J. Pathol., 166, 1691, 10.1016/S0002-9440(10)62479-0 · DOI · Paper page
  35. Gollnick, 2014, Not all acne is acne vulgaris, Dtsch. Arztebl Int., 111, 301
  36. Zouboulis, 2002, Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes, Proc. Natl. Acad. Sci. U.S.A., 99, 7148, 10.1073/pnas.102180999 · DOI · Paper page
  37. Gupta, 2015, Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?, Arch. Dermatol. Res., 307, 767, 10.1007/s00403-015-1571-1 · DOI
  38. Ramot, 2015, The role of PPARgamma-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology, Exp. Dermatol., 24, 245, 10.1111/exd.12647 · DOI
  39. Dozsa, 2014, PPARgamma-mediated and arachidonic acid-dependent signaling is involved in differentiation and lipid production of human sebocytes, J. Invest. Dermatol., 134, 910, 10.1038/jid.2013.413 · DOI
  40. Sears, 2007, Selective modulation of promoter recruitment and transcriptional activity of PPARgamma, Biochem. Biophys. Res. Commun., 364, 515, 10.1016/j.bbrc.2007.10.057 · DOI
  41. Dozsa, 2016, Decreased peroxisome proliferator-activated receptor gamma level and signalling in sebaceous glands of patients with acne vulgaris, Clin. Exp. Dermatol., 41, 547, 10.1111/ced.12794 · DOI
  42. Akaza, 2014, Fatty acid compositions of triglycerides and free fatty acids in sebum depend on amount of triglycerides, and do not differ in presence or absence of acne vulgaris, J. Dermatol., 41, 1069, 10.1111/1346-8138.12699 · DOI
  43. Kwon, 2015, Activity-guided purification identifies lupeol, a pentacyclic triterpene, as a therapeutic agent multiple pathogenic factors of acne, J. Invest. Dermatol., 135, 1491, 10.1038/jid.2015.29 · DOI

Cited by

See all 50

Metadata

Authors
Mastrofrancesco, A., Ottaviani, M., Cardinali, G., Flori, E., Briganti, S., Ludovici, M., Zouboulis, C. C., Lora, V., Camera, E., & Picardo, M.
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2017-08
Volume
138
Pages
96-106
ISSN
0006-2952
Cited by
50
References
10
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
Italian Minister of Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.